162 related articles for article (PubMed ID: 36182890)
1. Global trend of antimicrobial resistance in common bacterial pathogens in response to antibiotic consumption.
Hou J; Long X; Wang X; Li L; Mao D; Luo Y; Ren H
J Hazard Mater; 2023 Jan; 442():130042. PubMed ID: 36182890
[TBL] [Abstract][Full Text] [Related]
2. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.
Shrestha P; Cooper BS; Coast J; Oppong R; Do Thi Thuy N; Phodha T; Celhay O; Guerin PJ; Wertheim H; Lubell Y
Antimicrob Resist Infect Control; 2018; 7():98. PubMed ID: 30116525
[TBL] [Abstract][Full Text] [Related]
3. Global geographic trends in antimicrobial resistance: the role of international travel.
Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
[TBL] [Abstract][Full Text] [Related]
4. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015.
Klein EY; Van Boeckel TP; Martinez EM; Pant S; Gandra S; Levin SA; Goossens H; Laxminarayan R
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3463-E3470. PubMed ID: 29581252
[TBL] [Abstract][Full Text] [Related]
5. Differential Drivers of Antimicrobial Resistance across the World.
Vikesland P; Garner E; Gupta S; Kang S; Maile-Moskowitz A; Zhu N
Acc Chem Res; 2019 Apr; 52(4):916-924. PubMed ID: 30848890
[TBL] [Abstract][Full Text] [Related]
6. Global antimicrobial resistance: a system-wide comprehensive investigation using the Global One Health Index.
Zhou N; Cheng Z; Zhang X; Lv C; Guo C; Liu H; Dong K; Zhang Y; Liu C; Chang YF; Chen S; Guo X; Zhou XN; Li M; Zhu Y
Infect Dis Poverty; 2022 Aug; 11(1):92. PubMed ID: 35996187
[TBL] [Abstract][Full Text] [Related]
7. Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
Browne AJ; Chipeta MG; Haines-Woodhouse G; Kumaran EPA; Hamadani BHK; Zaraa S; Henry NJ; Deshpande A; Reiner RC; Day NPJ; Lopez AD; Dunachie S; Moore CE; Stergachis A; Hay SI; Dolecek C
Lancet Planet Health; 2021 Dec; 5(12):e893-e904. PubMed ID: 34774223
[TBL] [Abstract][Full Text] [Related]
8. Global surveillance of antimicrobial resistance and hypervirulence in Klebsiella pneumoniae from LMICs: An in-silico approach.
Silvester R; Madhavan A; Kokkat A; Parolla A; B M A; M H; Abdulla MH
Sci Total Environ; 2022 Jan; 802():149859. PubMed ID: 34464800
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis.
Ayobami O; Brinkwirth S; Eckmanns T; Markwart R
Emerg Microbes Infect; 2022 Dec; 11(1):443-451. PubMed ID: 35034585
[TBL] [Abstract][Full Text] [Related]
10. Exploring the factors that contribute to the successful implementation of antimicrobial resistance interventions: a comparison of high-income and low-middle-income countries.
Graells T; Lambraki IA; Cousins M; Léger A; Henriksson PJG; Troell M; Carson CA; Parmley EJ; Majowicz SE; Wernli D; Jørgensen PS
Front Public Health; 2023; 11():1230848. PubMed ID: 37900049
[TBL] [Abstract][Full Text] [Related]
11. Global patterns and correlates in the emergence of antimicrobial resistance in humans.
Mendelsohn E; Ross N; Zambrana-Torrelio C; Van Boeckel TP; Laxminarayan R; Daszak P
Proc Biol Sci; 2023 Sep; 290(2007):20231085. PubMed ID: 37727084
[TBL] [Abstract][Full Text] [Related]
12. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data.
Klein EY; Milkowska-Shibata M; Tseng KK; Sharland M; Gandra S; Pulcini C; Laxminarayan R
Lancet Infect Dis; 2021 Jan; 21(1):107-115. PubMed ID: 32717205
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
Sulis G; Sayood S; Gandra S
Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic consumption in developing countries defies global commitments: an overview on Brazilian growth in consumption.
Neves E Castro PB; da Silva Rodrigues DA; Roeser HMP; da Fonseca Santiago A; de Cássia Franco Afonso RJ
Environ Sci Pollut Res Int; 2020 Jun; 27(17):21013-21020. PubMed ID: 32266618
[TBL] [Abstract][Full Text] [Related]
15. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis.
Collignon P; Beggs JJ; Walsh TR; Gandra S; Laxminarayan R
Lancet Planet Health; 2018 Sep; 2(9):e398-e405. PubMed ID: 30177008
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance in low- and middle-income countries: current practices and its global implications.
Al Meslamani AZ
Expert Rev Anti Infect Ther; 2023; 21(12):1281-1286. PubMed ID: 37804134
[TBL] [Abstract][Full Text] [Related]
17. Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list.
Savoldi A; Carrara E; Gladstone BP; Azzini AM; Göpel S; Tacconelli E
J Antimicrob Chemother; 2019 Dec; 74(12):3619-3625. PubMed ID: 31730162
[TBL] [Abstract][Full Text] [Related]
18. Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis.
Lewnard JA; Charani E; Gleason A; Hsu LY; Khan WA; Karkey A; Chandler CIR; Mashe T; Khan EA; Bulabula ANH; Donado-Godoy P; Laxminarayan R
Lancet; 2024 Jun; 403(10442):2439-2454. PubMed ID: 38797180
[TBL] [Abstract][Full Text] [Related]
19. Socio-economic, governance and health indicators shaping antimicrobial resistance: an ecological analysis of 30 european countries.
Maugeri A; Barchitta M; Puglisi F; Agodi A
Global Health; 2023 Feb; 19(1):12. PubMed ID: 36829210
[TBL] [Abstract][Full Text] [Related]
20. Emergence of Global Antibiotic Resistance.
Morehead MS; Scarbrough C
Prim Care; 2018 Sep; 45(3):467-484. PubMed ID: 30115335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
